All In Biotech

Drug Trial Radar · NCT07527650

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate Efficacy, Safety, and Tolerability of HM15275 for 36 Weeks in Subjects With Type 2 Diabetes Mellitus

Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 180 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

180

Planned (sponsor's estimate)

Start

May 18, 2026

Primary completion

Oct 2027

Study completion Oct 2027

Sponsor

Sponsor type
Industry
First posted
Apr 14, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a Phase 2 clinical trial to evaluate the efficacy, safety, and tolerability of HM15275 in subjects with type 2 diabetes mellitus over 36 weeks.

Conditions

  • Type 2 Diabetes Mellitus
  • T2DM

Interventions

  • HM15275Drug

    HM15275 is a sterile solution for subcutaneous injection, supplied pre-filled syringes.

  • Placebo of HM15275Drug

    A sterile, matching solution supplied in pre-filled syringes.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Glycated Hemoglobin (HbA1c)Time frame: Up to 41 weeks

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • Desert Clinical Research

    Mesa, Arizona · Recruiting

  • Care Access Research - Santa Clarita

    Santa Clarita, California · Recruiting

  • Accel Research Sites - DeLand

    DeLand, Florida · Recruiting

  • Charter Research

    Orlando, Florida · Recruiting

  • AdventHealth Translational Research Institute

    Orlando, Florida · Recruiting

  • K2 Medical Research The Villages LLC

    The Villages, Florida · Recruiting

  • Charter Research - The Villages

    The Villages, Florida · Recruiting

  • Centricity Research IRT - DBA IACT Health Columbus Piedmont

    Columbus, Georgia · Recruiting

  • Charter Research - Chicago

    Chicago, Illinois · Recruiting

  • The South Bend Clinic

    South Bend, Indiana · Recruiting

  • Jefferson City Medical Center

    Jefferson City, Missouri · Recruiting

  • Clay Platte Family Medicine

    Kansas City, Missouri · Recruiting

  • Methodist Physicians Clinic

    Fremont, Nebraska · Recruiting

  • Santa Rosa Medical Centers of Nevada

    Las Vegas, Nevada · Recruiting

  • Lucas Research, Inc.

    Morehead City, North Carolina · Recruiting

  • Centricity Research Columbus

    Columbus, Ohio · Recruiting

  • DM Clinical Research

    Tomball, Texas · Recruiting

  • Olympus Family Medicine

    Salt Lake City, Utah · Recruiting

  • Highland Clinical Research

    Salt Lake City, Utah · Recruiting

  • Manassas Clinical Research Center

    Manassas, Virginia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.